Nomad Power Solutions (NMAD)


Market Price (8/6/2026): $3.9 | Market Cap: $42.5 MilSector: Industrials | Industry: Electrical Components & Equipment

Nomad Power Solutions (NMAD)


Market Price (8/6/2026): $3.9
Market Cap: $42.5 Mil
Sector: Industrials
Industry: Electrical Components & Equipment

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Megatrend and thematic drivers
Megatrends include Renewable Energy Transition, Electrification of Everything, and Smart Grids & Grid Modernization. Themes include Battery Storage & Grid Modernization, Show more.

Weak multi-year price returns
3Y Excs Rtn is -58%

Very low revenue
Rev LTMTotal Revenue or Sales, Last Twelve Months is 0

Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -6.4 Mil

Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -21%

Key risks
NMAD key risks include [1] substantial execution risk following its complete strategic pivot from biotechnology to AI energy infrastructure and [2] a limited operating history and financial transparency in its new business, Show more.

0 Megatrend and thematic drivers
Megatrends include Renewable Energy Transition, Electrification of Everything, and Smart Grids & Grid Modernization. Themes include Battery Storage & Grid Modernization, Show more.
1 Weak multi-year price returns
3Y Excs Rtn is -58%
2 Very low revenue
Rev LTMTotal Revenue or Sales, Last Twelve Months is 0
3 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -6.4 Mil
4 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -21%
5 Key risks
NMAD key risks include [1] substantial execution risk following its complete strategic pivot from biotechnology to AI energy infrastructure and [2] a limited operating history and financial transparency in its new business, Show more.

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 8/5/2026

Nomad Power Solutions (NMAD) stock has gained about 10% since 4/30/2026 because of the following key factors:

1. Strategic Corporate Rebranding and Sector Focus.

On July 6, 2026, LIXTE Biotechnology Holdings, Inc. officially changed its name to Nomad Power Solutions, Inc., and began trading under the new Nasdaq ticker NMAD. This move signaled a strategic re-focusing of the company's core business towards the high-growth AI energy infrastructure equipment and services sector, following the recent acquisition of NOMAD Transportable Power Systems.

2. Significant Customer Validation with DSO Electric Cooperative.

In late July 2026, Nomad Power Solutions announced that DSO Electric Cooperative transitioned from a successful 2025 pilot program to purchasing two NOMAD Traveler Battery Energy Storage Systems for ongoing seasonal operation. The pilot projected over $100,000 in seasonal demand-charge savings, providing strong commercial validation for Nomad Power Solutions' mobile battery storage technology.

Show more
Updated on 8/5/2026

Nomad Power Solutions (NMAD) stock has gained about 10% since 4/30/2026 because of the following key factors:

1. Strategic Corporate Rebranding and Sector Focus.

On July 6, 2026, LIXTE Biotechnology Holdings, Inc. officially changed its name to Nomad Power Solutions, Inc., and began trading under the new Nasdaq ticker NMAD. This move signaled a strategic re-focusing of the company's core business towards the high-growth AI energy infrastructure equipment and services sector, following the recent acquisition of NOMAD Transportable Power Systems.

2. Significant Customer Validation with DSO Electric Cooperative.

In late July 2026, Nomad Power Solutions announced that DSO Electric Cooperative transitioned from a successful 2025 pilot program to purchasing two NOMAD Traveler Battery Energy Storage Systems for ongoing seasonal operation. The pilot projected over $100,000 in seasonal demand-charge savings, providing strong commercial validation for Nomad Power Solutions' mobile battery storage technology.

3. Enhanced Product Capacity.

On July 8, 2026, NOMAD announced a significant upgrade to its Voyager Fleet Energy Storage, increasing capacity by up to 56%. This enhancement brought the Eagle and Falcon units to 2.025 MWh by integrating Octillion's prismatic LFP architecture, positioning the company to better serve the escalating power demands from data centers and hyperscale operations.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 11.1% change in NMAD stock from 4/30/2026 to 8/5/2026 was primarily driven by a 0.0% change in the company's Total Revenues ($ Mil).
(LTM values as of)43020268052026Change
Stock Price ($)3.503.8911.1%
Change Contribution By: 
Total Revenues ($ Mil)000.0%
P/S Multiple0.0%
Shares Outstanding (Mil)911-19.3%
Cumulative Contribution0.0%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 8/5/2026
ReturnCorrelation
NMAD11.1% 
Market (SPY)7.1%12.7%
Sector (XLI)6.7%3.2%

Fundamental Drivers

The 4.6% change in NMAD stock from 1/31/2026 to 8/5/2026 was primarily driven by a 0.0% change in the company's Total Revenues ($ Mil).
(LTM values as of)13120268052026Change
Stock Price ($)3.723.894.6%
Change Contribution By: 
Total Revenues ($ Mil)000.0%
P/S Multiple0.0%
Shares Outstanding (Mil)611-43.3%
Cumulative Contribution0.0%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 8/5/2026
ReturnCorrelation
NMAD4.6% 
Market (SPY)11.5%14.0%
Sector (XLI)13.0%4.9%

Fundamental Drivers

The -2.0% change in NMAD stock from 7/31/2025 to 8/5/2026 was primarily driven by a -77.3% change in the company's Shares Outstanding (Mil).
(LTM values as of)73120258052026Change
Stock Price ($)3.973.89-2.0%
Change Contribution By: 
Total Revenues ($ Mil)000.0%
P/S Multiple0.0%
Shares Outstanding (Mil)211-77.3%
Cumulative Contribution0.0%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 8/5/2026
ReturnCorrelation
NMAD-2.0% 
Market (SPY)22.8%8.8%
Sector (XLI)23.9%-0.2%

Fundamental Drivers

The 10.5% change in NMAD stock from 7/31/2023 to 8/5/2026 was primarily driven by a 0.0% change in the company's Total Revenues ($ Mil).
(LTM values as of)73120238052026Change
Stock Price ($)3.523.8910.5%
Change Contribution By: 
Total Revenues ($ Mil)000.0%
P/S Multiple0.0%
Shares Outstanding (Mil)211-84.7%
Cumulative Contribution0.0%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2023 to 8/5/2026
ReturnCorrelation
NMAD10.5% 
Market (SPY)74.1%8.9%
Sector (XLI)75.8%6.9%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
NMAD Return-62%-57%-54%-14%94%-5%-88%
Peers Return19%-49%30%-9%22%-3%-15%
S&P 500 Return27%-19%24%23%16%13%106%

Monthly Win Rates [3]
NMAD Win Rate17%33%42%50%42%50% 
Peers Win Rate57%33%52%47%53%55% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
NMAD Max Drawdown-79%-81%-91%-65%-75%-53% 
Peers Max Drawdown-41%-65%-46%-44%-58%-47% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: TSLA, GNRC, STEM, FLNC, ENS.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/5/2026 (YTD)

How Low Can It Go

EventNMADS&P 500
2025 US Tariff Shock
  % Loss-22.7%-18.8%
  % Gain to Breakeven29.4%23.1%
  Time to Breakeven63 days79 days
2024 Yen Carry Trade Unwind
  % Loss-11.5%-7.8%
  % Gain to Breakeven13.0%8.5%
  Time to Breakeven123 days18 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-55.2%-9.5%
  % Gain to Breakeven123.4%10.5%
  Time to Breakeven660 days24 days
2022 Inflation Shock & Fed Tightening
  % Loss-61.5%-24.5%
  % Gain to Breakeven160.0%32.4%
  Time to Breakeven137 days427 days
2020 COVID-19 Crash
  % Loss-25.0%-33.7%
  % Gain to Breakeven33.3%50.9%
  Time to Breakeven25 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-12.5%-19.2%
  % Gain to Breakeven14.3%23.8%
  Time to Breakeven1 days105 days

Compare to TSLA, GNRC, STEM, FLNC, ENS

In The Past

Nomad Power Solutions's stock fell -22.7% during the 2025 US Tariff Shock. Such a loss loss requires a 29.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventNMADS&P 500
2025 US Tariff Shock
  % Loss-22.7%-18.8%
  % Gain to Breakeven29.4%23.1%
  Time to Breakeven63 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-55.2%-9.5%
  % Gain to Breakeven123.4%10.5%
  Time to Breakeven660 days24 days
2022 Inflation Shock & Fed Tightening
  % Loss-61.5%-24.5%
  % Gain to Breakeven160.0%32.4%
  Time to Breakeven137 days427 days
2020 COVID-19 Crash
  % Loss-25.0%-33.7%
  % Gain to Breakeven33.3%50.9%
  Time to Breakeven25 days140 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-52.8%-3.7%
  % Gain to Breakeven111.8%3.9%
  Time to Breakeven3 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-20.0%-12.2%
  % Gain to Breakeven25.0%13.9%
  Time to Breakeven5 days62 days
2014-2016 Oil Price Collapse
  % Loss-79.6%-6.8%
  % Gain to Breakeven390.0%7.3%
  Time to Breakeven45 days15 days
2013 Taper Tantrum
  % Loss-40.0%-0.2%
  % Gain to Breakeven66.7%0.2%
  Time to Breakeven2 days1 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-53.3%-17.9%
  % Gain to Breakeven114.3%21.8%
  Time to Breakeven129 days123 days
2010 Eurozone Sovereign Debt Crisis / Flash Crash
  % Loss-30.0%-15.4%
  % Gain to Breakeven42.9%18.2%
  Time to Breakeven52 days125 days
2008-2009 Global Financial Crisis
  % Loss-80.0%-53.4%
  % Gain to Breakeven400.0%114.4%
  Time to Breakeven230 days1085 days

Compare to TSLA, GNRC, STEM, FLNC, ENS

In The Past

Nomad Power Solutions's stock fell -22.7% during the 2025 US Tariff Shock. Such a loss loss requires a 29.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Nomad Power Solutions (NMAD)

Nomad Power Solutions (NMAD) operates as a drug discovery company dedicated to identifying and developing novel treatments for serious common and chronic diseases. The company leverages advanced biomarker technology to pinpoint enzyme targets implicated in various illnesses. It then designs innovative compounds, primarily focusing on inhibitors of protein phosphatases, which can be used alone or in combination with other therapeutic agents like cytotoxic drugs, x-ray therapy, or immune checkpoint blockers.

The company's product pipeline includes two main series of pharmacologically active drugs. The LB-100 series consists of novel structures aimed at treating cancers, vascular diseases, and metabolic disorders. Complementing this, the LB-200 series is designed to address chronic hereditary conditions such as Gaucher's disease, as well as certain types of cancer and neurodegenerative diseases. These drug candidates are at various stages of pre-clinical and clinical development.

Nomad Power Solutions actively engages in clinical research and development through strategic partnerships. It has clinical trial research agreements with institutions such as the Moffitt Cancer Center and Research Institute Hospital Inc., and collaboration agreements for investigator-initiated clinical trials with organizations like the Spanish Sarcoma Group, the Netherlands Cancer Institute, and the Oncode Institute. Founded in 2005, the company targets the broad pharmaceutical and biotechnology markets, aiming to provide solutions for significant unmet medical needs.

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

Based on the provided background information, Nomad Power Solutions (symbol: NMAD) is described as Lixte Biotechnology Holdings, Inc., a drug discovery company.

Lixte Biotechnology Holdings, Inc. operates in the pre-clinical and clinical development stages, focusing on identifying enzyme targets and designing novel compounds for the treatment of various diseases. The company is described as having clinical trial research agreements and collaboration agreements with institutions such as:

  • Moffitt Cancer Center and Research Institute Hospital Inc.
  • Spanish Sarcoma Group
  • Netherlands Cancer Institute
  • Oncode Institute

These entities serve as research partners and collaborators for clinical trials and development, rather than traditional commercial customers that purchase developed products or services from Nomad Power Solutions (Lixte Biotechnology Holdings, Inc.). As the company is described as being in discovery and development phases for its drug compounds, it does not currently appear to have major commercial customers that are purchasing its products or services. Its revenue streams would typically come from grants, investor funding, or potential future licensing deals, which are not detailed as "customers" in the context of this request.

Therefore, based on the provided description, Nomad Power Solutions (Lixte Biotechnology Holdings, Inc.) does not currently have identifiable major customers in the traditional sense of entities purchasing its products or services.

AI Analysis | Feedback

null

AI Analysis | Feedback

Geordan Pursglove

Chief Executive Officer Geordan Pursglove is leading Nomad Power Solutions (formerly Lixte Biotechnology Holdings, Inc.) through its strategic transformation into an AI energy infrastructure equipment and services platform, following the acquisition of NOMAD Transportable Power Systems. He has emphasized the significant, scalable growth opportunities and potential for long-term shareholder value within the broad AI energy sector.

Braxten Gorrill

Chief Financial Officer Braxten Gorrill serves as the Chief Financial Officer for Nomad Power Solutions.

John Francis Travaglini

CEO & President John Francis Travaglini holds the titles of CEO and President at Nomad Power Solutions.

Chris McKay

Chief Operating Officer Chris McKay is the Chief Operating Officer of Nomad Power Solutions.

Jason Sawyer

General Manager, Access Alternative Group S.A. Jason Sawyer is a 30-year veteran of the alternative investment industry and serves as General Manager of Access Alternative Group S.A. (AAG), a venture investment and advisory firm. He has led over $200 million in early and growth-stage investments across various sectors, including fintech, biotech, software, energy, and consumer products. Sawyer was previously a Principal at Crane Capital (which was sold to Bear Stearns) and co-founded Candlebrook Capital. He has successfully co-founded and financed companies such as Caary Capital, Pacific West Stone, Sanna Health, and California Fitness, with successful exits and institutional backing.

AI Analysis | Feedback

The key risks to Nomad Power Solutions (symbol: NMAD) are as follows:
  1. Strategic Pivot and Execution Risk: Nomad Power Solutions has undergone a complete business transformation, shifting its core focus from biotechnology to providing AI energy infrastructure equipment and services. This significant strategic pivot introduces substantial execution risks, as the company must prove its ability to successfully compete and gain market share in an entirely new industry, potentially signaling a loss of core expertise and revenue sources from its former life sciences market.
  2. Intense Competition in the AI Energy Infrastructure Market: The company operates in the rapidly expanding and competitive AI energy infrastructure sector. Nomad Power Solutions faces inherent risks associated with market volatility and intense competition from other battery makers and various energy storage and delivery solution providers.
  3. Limited Operating History and Financial Transparency in New Business: Due to its recent corporate name change and strategic reorientation, Nomad Power Solutions has limited operating history in its new AI energy infrastructure focus. This, coupled with a current lack of sufficient analyst coverage and historical financial data relevant to its new business model, makes it challenging for investors and analysts to reliably forecast future earnings and assess the company's long-term financial performance.

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

Nomad Power Solutions (NMAD), formerly Lixte Biotechnology Holdings, Inc., has made several capital allocation decisions over the last three to five years, particularly leading up to its recent strategic transformation into an AI energy infrastructure equipment and services platform.

Share Issuance

  • In June 2026, the company completed a registered direct offering, selling 2,366,503 shares of common stock and pre-funded warrants to purchase an additional 258,859 shares, raising approximately $16.6 million in gross proceeds.
  • As part of the merger with NOMAD Transportable Power Systems, which closed in July 2026, Lixte Biotechnology Holdings, Inc. issued 2,992,041 shares of common stock and 50,366.07 shares of newly authorized Series D preferred stock to NOMAD accredited stockholders. The preferred shares are convertible into 50,366,070 shares of common stock upon stockholder approval.

Outbound Investments

  • In June 2026, LIXTE Biotechnology signed a definitive agreement to acquire 100% of NOMAD Transportable Power Systems, a leader in mobile, utility-grade battery energy storage systems, which subsequently led to Lixte's rebranding to Nomad Power Solutions.
  • As part of the NOMAD acquisition, LIXTE provided a $6.5 million loan to NOMAD Transportable Power Systems to support its operations and order pipeline.
  • In November 2025, Lixte acquired Liora Technologies Europe Ltd. through a Share Exchange Agreement, gaining assets related to the LIGHT (Linac Guided Hadron Therapy) proton-based radiotherapy solution.

Capital Expenditures

  • For fiscal years 2021 through 2025, and the first quarter of fiscal year 2026, the company reported negligible or no separate capital expenditures.

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

NMADTSLAGNRCSTEMFLNCENSMedian
NameNomad Po.Tesla Generac Stem Fluence .EnerSys  
Mkt Price3.89321.55217.415.8014.23189.87102.05
Mkt Cap0.01,040.912.80.01.97.04.4
Rev LTM0103,6194,4391532,5853,7513,168
Op Inc LTM-64,772421-45-50477208
FCF LTM-45,755379-14-269468187
FCF 3Y Avg-44,353469-81-146326161
CFO LTM-418,685548-10-236548272
CFO 3Y Avg-415,327626-70-121422209

Growth & Margins

NMADTSLAGNRCSTEMFLNCENSMedian
NameNomad Po.Tesla Generac Stem Fluence .EnerSys  
Rev Chg LTM-11.8%0.6%0.7%10.9%3.7%3.7%
Rev Chg 3Y Avg-3.5%3.4%-18.4%15.7%0.4%3.4%
Rev Chg Q-25.5%10.6%-10.8%7.7%1.3%7.7%
QoQ Delta Rev Chg LTM-5.9%2.6%-2.2%1.3%0.4%1.3%
Op Inc Chg LTM-92.8%-17.4%-25.0%67.8%-87.3%-1.5%-21.2%
Op Inc Chg 3Y Avg-13.8%-26.8%12.6%17.1%13.2%18.2%12.9%
Op Mgn LTM-4.6%9.5%-29.7%-1.9%12.7%4.6%
Op Mgn 3Y Avg-6.1%10.9%-57.2%-2.1%12.4%6.1%
QoQ Delta Op Mgn LTM--0.8%2.0%5.9%0.3%-0.0%0.3%
CFO/Rev LTM-18.0%12.3%-6.5%-9.1%14.6%12.3%
CFO/Rev 3Y Avg-15.7%14.6%-21.9%-4.7%11.5%11.5%
FCF/Rev LTM-5.6%8.5%-9.4%-10.4%12.5%5.6%
FCF/Rev 3Y Avg-4.5%11.0%-26.8%-5.8%8.9%4.5%

Valuation

NMADTSLAGNRCSTEMFLNCENSMedian
NameNomad Po.Tesla Generac Stem Fluence .EnerSys  
Mkt Cap0.01,040.912.80.01.97.04.4
P/S-10.02.90.30.71.91.9
P/Op Inc-6.6218.130.3-1.1-37.814.66.8
P/EBIT-5.8187.531.60.3-37.817.58.9
P/E-5.9273.649.50.3-45.123.712.0
P/CFO-9.855.723.3-4.9-8.012.73.9
Total Yield-17.1%0.4%2.0%291.2%-2.2%4.8%1.2%
Dividend Yield0.0%0.0%0.0%0.0%0.0%0.5%0.0%
FCF Yield 3Y Avg-69.5%0.4%4.9%-749.1%-12.7%6.1%-6.1%
D/E0.00.00.16.70.20.20.1
Net D/E-0.1-0.00.15.90.00.10.0

Returns

NMADTSLAGNRCSTEMFLNCENSMedian
NameNomad Po.Tesla Generac Stem Fluence .EnerSys  
1M Rtn-47.0%-23.4%-15.7%-25.5%-20.1%-11.0%-21.8%
3M Rtn-11.6%-19.4%-18.7%-46.8%4.9%-15.2%-16.9%
6M Rtn20.8%-20.8%22.7%-59.6%-50.9%2.9%-8.9%
12M Rtn-11.2%4.2%10.2%-51.3%66.4%109.2%7.2%
3Y Rtn21.6%26.7%90.8%-95.8%-49.9%86.6%24.1%
1M Excs Rtn-39.2%-23.1%-10.7%-22.1%-15.1%-6.0%-18.6%
3M Excs Rtn-19.7%-23.8%-23.9%-51.6%5.7%-20.2%-22.0%
6M Excs Rtn3.4%-35.4%13.8%-73.9%-67.5%-11.4%-23.4%
12M Excs Rtn-42.0%-18.0%-11.3%-79.0%45.8%87.7%-14.7%
3Y Excs Rtn-57.8%-48.1%-26.9%-164.2%-119.6%11.7%-52.9%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil202420232022
Development of a drug class called Protein Phosphatase 2A inhibitors000
Total000


Assets by Segment
$ Mil20252024202320222021
Development of cancer treatments131   
Development of a drug class called Protein Phosphatase 2A inhibitors  465
Total131465


Price Behavior

Price Behavior
Market Price$3.89 
Market Cap ($ Bil)0.0 
First Trading Date09/21/2007 
Distance from 52W High-51.6% 
   50 Days200 Days
DMA Price$6.15$4.33
DMA Trendupup
Distance from DMA-36.7%-10.2%
 3M1YR
Volatility115.5%99.1%
Downside Capture109.7372.63
Upside Capture34.7441.59
Correlation (SPY)9.1%12.3%
NMAD Betas & Captures as of 7/31/2026

 1M2M3M6M1Y3Y
Beta3.142.042.021.430.870.77
Up Beta3.745.234.971.651.060.80
Down Beta0.73-1.010.071.491.540.91
Up Capture13%125%264%152%53%28%
Bmk +ve Days11223567138427
Stock +ve Days9203056111343
Down Capture644%271%137%123%61%84%
Bmk -ve Days11212859114326
Stock -ve Days13223267136384

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with NMAD
NMAD-20.0%99.4%0.21-
Sector ETF (XLI)24.7%17.0%1.131.9%
Equity (SPY)23.1%12.9%1.3412.2%
Gold (GLD)25.4%28.3%0.796.5%
Commodities (DBC)29.5%19.8%1.19-1.5%
Real Estate (VNQ)14.4%13.7%0.74-13.7%
Bitcoin (BTCUSD)-44.6%42.9%-1.2511.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with NMAD
NMAD-32.1%137.0%0.26-
Sector ETF (XLI)14.3%17.6%0.646.9%
Equity (SPY)13.4%17.2%0.6010.0%
Gold (GLD)18.2%18.6%0.792.2%
Commodities (DBC)8.1%19.6%0.313.3%
Real Estate (VNQ)2.5%18.9%0.034.3%
Bitcoin (BTCUSD)9.9%53.0%0.376.5%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with NMAD
NMAD4.0%177.8%0.74-
Sector ETF (XLI)14.2%20.0%0.623.6%
Equity (SPY)15.3%17.9%0.734.9%
Gold (GLD)12.0%16.2%0.601.0%
Commodities (DBC)7.1%18.0%0.312.0%
Real Estate (VNQ)4.9%20.7%0.202.3%
Bitcoin (BTCUSD)58.2%66.2%0.980.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date7152026
Short Interest: Shares Quantity1.0 Mil
Short Interest: % Change Since 630202638.9%
Average Daily Volume0.6 Mil
Days-to-Cover Short Interest1.7 days
Basic Shares Quantity10.9 Mil
Short % of Basic Shares9.1%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/14/202610-Q
12/31/202503/31/202610-K
09/30/202511/12/202510-Q
06/30/202508/07/202510-Q
03/31/202505/12/202510-Q
12/31/202403/24/202510-K
09/30/202411/12/202410-Q
06/30/202408/08/202410-Q
03/31/202405/09/202410-Q
12/31/202303/19/202410-K
09/30/202311/09/202310-Q
06/30/202308/09/202310-Q
03/31/202305/10/202310-Q
12/31/202203/29/202310-K
09/30/202211/08/202210-Q
06/30/202208/10/202210-Q
Collapse to Preview
Report DateFiling DateFiling
03/31/202605/14/202610-Q
12/31/202503/31/202610-K
09/30/202511/12/202510-Q
06/30/202508/07/202510-Q
03/31/202505/12/202510-Q
12/31/202403/24/202510-K
09/30/202411/12/202410-Q
06/30/202408/08/202410-Q
03/31/202405/09/202410-Q
12/31/202303/19/202410-K
09/30/202311/09/202310-Q
06/30/202308/09/202310-Q
03/31/202305/10/202310-Q
12/31/202203/29/202310-K
09/30/202211/08/202210-Q
06/30/202208/10/202210-Q
03/31/202205/11/202210-Q
12/31/202103/21/202210-K
09/30/202111/10/202110-Q
06/30/202108/10/202110-Q
03/31/202105/12/202110-Q
12/31/202003/26/202110-K
09/30/202011/10/202010-Q
06/30/202008/10/202010-Q
03/31/202005/11/202010-Q
12/31/201903/25/202010-K
09/30/201911/08/201910-Q
06/30/201908/06/201910-Q
Core Cache Last Updated: 8/5/2026